US Stock MarketDetailed Quotes

AIM ImmunoTech (AIM)

Watchlist
  • 0.5377
  • +0.0567+11.79%
Trading May 7 11:31 ET
4.38MMarket Cap-0.06P/E (TTM)

AIM ImmunoTech (AIM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-48.24%88K
-53.33%21K
-25.71%26K
-50.00%25K
-60.00%16K
-15.84%170K
-30.77%45K
-23.91%35K
19.05%50K
-18.37%40K
Operating revenue
-48.24%88K
-53.33%21K
-25.71%26K
-50.00%25K
-60.00%16K
-15.84%170K
-30.77%45K
-23.91%35K
19.05%50K
-18.37%40K
Cost of revenue
312.90%128K
471.43%40K
750.00%68K
25.00%10K
25.00%10K
-26.19%31K
-41.67%7K
-73.33%8K
8K
8K
Gross profit
-128.78%-40K
-150.00%-19K
-255.56%-42K
-64.29%15K
-81.25%6K
-13.13%139K
-28.30%38K
68.75%27K
0.00%42K
-34.69%32K
Operating expense
-41.62%11.62M
-50.23%2.93M
-46.74%2.41M
-28.77%2.66M
-37.13%3.63M
-37.93%19.91M
-58.08%5.89M
-44.74%4.52M
-32.11%3.74M
32.73%5.77M
Selling and administrative expenses
-43.85%7.7M
-55.78%1.87M
-41.60%1.8M
-42.61%1.49M
-33.29%2.55M
-35.12%13.71M
-61.05%4.23M
-43.39%3.08M
1.61%2.59M
66.45%3.82M
-General and administrative expense
-43.85%7.7M
-55.78%1.87M
-41.60%1.8M
-42.61%1.49M
-33.29%2.55M
-35.12%13.71M
-61.05%4.23M
-43.39%3.08M
1.61%2.59M
66.45%3.82M
Research and development costs
-36.68%3.92M
-36.12%1.06M
-57.76%607K
2.53%1.17M
-44.64%1.08M
-43.35%6.2M
-48.00%1.66M
-47.44%1.44M
-61.23%1.15M
-4.92%1.95M
Operating profit
41.01%-11.66M
49.58%-2.95M
45.49%-2.45M
28.37%-2.65M
36.89%-3.62M
38.05%-19.77M
58.19%-5.86M
44.97%-4.49M
32.36%-3.69M
-33.50%-5.73M
Net non-operating interest income expense
-48.53%2.37M
-116.72%-281K
462.79%2.9M
-105.79%-139K
-1,355.56%-113K
330.96%4.61M
551.55%1.68M
75.51%516K
655.03%2.4M
-95.48%9K
Non-operating interest income
-38.69%3.18M
-93.93%110K
325.07%3.05M
-99.61%10K
-86.42%11K
385.69%5.19M
602.71%1.81M
144.22%718K
711.32%2.58M
-59.30%81K
Non-operating interest expense
38.80%812K
196.21%391K
-26.73%148K
-16.76%149K
72.22%124K
--585K
--132K
--202K
--179K
--72K
Other net income (expense)
-116.47%-4.67M
47.46%-942K
-1,470.33%-3.74M
98.34%-9K
129.35%27K
-214.32%-2.16M
-253.25%-1.79M
480.85%273K
-332.05%-543K
-121.15%-92K
Gain on sale of security
-668.06%-4.23M
-398.41%-942K
-1,311.72%-3.31M
98.34%-9K
129.35%27K
-375.50%-551K
-147.13%-189K
188.06%273K
-477.66%-543K
-145.32%-92K
Special income (charges)
----
----
----
----
----
--0
--0
--0
--0
--0
-Gain on sale of property,plant,equipment
----
----
----
----
----
--0
--0
--0
--0
--0
Other non- operating income (expenses)
73.00%-433K
--0
---433K
----
----
-196.22%-1.6M
----
----
----
----
Income before tax
19.41%-13.96M
30.03%-4.18M
11.24%-3.28M
-52.18%-2.79M
36.31%-3.71M
40.20%-17.32M
52.55%-5.97M
52.66%-3.7M
62.60%-1.84M
-58.89%-5.82M
Income tax
Net income
19.41%-13.96M
30.03%-4.18M
11.24%-3.28M
-52.18%-2.79M
36.31%-3.71M
40.20%-17.32M
52.55%-5.97M
52.66%-3.7M
62.60%-1.84M
-58.89%-5.82M
Net income continuous Operations
19.41%-13.96M
30.03%-4.18M
11.24%-3.28M
-52.18%-2.79M
36.31%-3.71M
40.20%-17.32M
52.55%-5.97M
52.66%-3.7M
62.60%-1.84M
-58.89%-5.82M
Minority interest income
Net income attributable to the parent company
19.41%-13.96M
30.03%-4.18M
11.24%-3.28M
-52.18%-2.79M
36.31%-3.71M
40.20%-17.32M
52.55%-5.97M
52.66%-3.7M
62.60%-1.84M
-58.89%-5.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
19.41%-13.96M
30.03%-4.18M
11.24%-3.28M
-52.18%-2.79M
36.31%-3.71M
40.20%-17.32M
52.55%-5.97M
52.66%-3.7M
62.60%-1.84M
-58.89%-5.82M
Basic earnings per share
72.12%-8.62
86.33%-1.3586
73.83%-1.5684
-22.67%-3.6763
58.33%-4.995
48.42%-30.92
61.73%-9.941
62.50%-5.994
70.00%-2.997
-50.00%-11.988
Diluted earnings per share
72.12%-8.62
86.33%-1.3586
73.83%-1.5684
-22.67%-3.6763
58.33%-4.995
48.42%-30.92
61.73%-9.941
62.50%-5.994
70.00%-2.997
-50.00%-11.988
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -48.24%88K-53.33%21K-25.71%26K-50.00%25K-60.00%16K-15.84%170K-30.77%45K-23.91%35K19.05%50K-18.37%40K
Operating revenue -48.24%88K-53.33%21K-25.71%26K-50.00%25K-60.00%16K-15.84%170K-30.77%45K-23.91%35K19.05%50K-18.37%40K
Cost of revenue 312.90%128K471.43%40K750.00%68K25.00%10K25.00%10K-26.19%31K-41.67%7K-73.33%8K8K8K
Gross profit -128.78%-40K-150.00%-19K-255.56%-42K-64.29%15K-81.25%6K-13.13%139K-28.30%38K68.75%27K0.00%42K-34.69%32K
Operating expense -41.62%11.62M-50.23%2.93M-46.74%2.41M-28.77%2.66M-37.13%3.63M-37.93%19.91M-58.08%5.89M-44.74%4.52M-32.11%3.74M32.73%5.77M
Selling and administrative expenses -43.85%7.7M-55.78%1.87M-41.60%1.8M-42.61%1.49M-33.29%2.55M-35.12%13.71M-61.05%4.23M-43.39%3.08M1.61%2.59M66.45%3.82M
-General and administrative expense -43.85%7.7M-55.78%1.87M-41.60%1.8M-42.61%1.49M-33.29%2.55M-35.12%13.71M-61.05%4.23M-43.39%3.08M1.61%2.59M66.45%3.82M
Research and development costs -36.68%3.92M-36.12%1.06M-57.76%607K2.53%1.17M-44.64%1.08M-43.35%6.2M-48.00%1.66M-47.44%1.44M-61.23%1.15M-4.92%1.95M
Operating profit 41.01%-11.66M49.58%-2.95M45.49%-2.45M28.37%-2.65M36.89%-3.62M38.05%-19.77M58.19%-5.86M44.97%-4.49M32.36%-3.69M-33.50%-5.73M
Net non-operating interest income expense -48.53%2.37M-116.72%-281K462.79%2.9M-105.79%-139K-1,355.56%-113K330.96%4.61M551.55%1.68M75.51%516K655.03%2.4M-95.48%9K
Non-operating interest income -38.69%3.18M-93.93%110K325.07%3.05M-99.61%10K-86.42%11K385.69%5.19M602.71%1.81M144.22%718K711.32%2.58M-59.30%81K
Non-operating interest expense 38.80%812K196.21%391K-26.73%148K-16.76%149K72.22%124K--585K--132K--202K--179K--72K
Other net income (expense) -116.47%-4.67M47.46%-942K-1,470.33%-3.74M98.34%-9K129.35%27K-214.32%-2.16M-253.25%-1.79M480.85%273K-332.05%-543K-121.15%-92K
Gain on sale of security -668.06%-4.23M-398.41%-942K-1,311.72%-3.31M98.34%-9K129.35%27K-375.50%-551K-147.13%-189K188.06%273K-477.66%-543K-145.32%-92K
Special income (charges) ----------------------0--0--0--0--0
-Gain on sale of property,plant,equipment ----------------------0--0--0--0--0
Other non- operating income (expenses) 73.00%-433K--0---433K---------196.22%-1.6M----------------
Income before tax 19.41%-13.96M30.03%-4.18M11.24%-3.28M-52.18%-2.79M36.31%-3.71M40.20%-17.32M52.55%-5.97M52.66%-3.7M62.60%-1.84M-58.89%-5.82M
Income tax
Net income 19.41%-13.96M30.03%-4.18M11.24%-3.28M-52.18%-2.79M36.31%-3.71M40.20%-17.32M52.55%-5.97M52.66%-3.7M62.60%-1.84M-58.89%-5.82M
Net income continuous Operations 19.41%-13.96M30.03%-4.18M11.24%-3.28M-52.18%-2.79M36.31%-3.71M40.20%-17.32M52.55%-5.97M52.66%-3.7M62.60%-1.84M-58.89%-5.82M
Minority interest income
Net income attributable to the parent company 19.41%-13.96M30.03%-4.18M11.24%-3.28M-52.18%-2.79M36.31%-3.71M40.20%-17.32M52.55%-5.97M52.66%-3.7M62.60%-1.84M-58.89%-5.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 19.41%-13.96M30.03%-4.18M11.24%-3.28M-52.18%-2.79M36.31%-3.71M40.20%-17.32M52.55%-5.97M52.66%-3.7M62.60%-1.84M-58.89%-5.82M
Basic earnings per share 72.12%-8.6286.33%-1.358673.83%-1.5684-22.67%-3.676358.33%-4.99548.42%-30.9261.73%-9.94162.50%-5.99470.00%-2.997-50.00%-11.988
Diluted earnings per share 72.12%-8.6286.33%-1.358673.83%-1.5684-22.67%-3.676358.33%-4.99548.42%-30.9261.73%-9.94162.50%-5.99470.00%-2.997-50.00%-11.988
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran negotiations have entered a critical window period amid external expectations and the strategic interactions of all parties, wit Show More